Sanjuliani AF, Francischetti EA, Genelhu de Abreu V, Ueleres Braga J Effects of Moxonidine on the Sympathetic Nervous System, Blood Pressure, Plasma Renin Activity, Plasma Aldosterone, Leptin, and Metabolic Profile in Obese Hypertensive Patients Journal of Clinical and Basic Cardiology 2004; 7 (1-4): 19-25 PDF Summary Overview
| ||||
Figure/Graphic 1: Moxonidine - Clinical evaluation Study flow chart. Clinical evaluation: all visits; ambulatory blood pressure: visit 1 and 7; venous and arterial blood sample for assessment of catecholamines, insulin, glucose, leptin, plasma renin activity, plama aldosterone, total cholesterol, triglycerides, HDL-C and LDL-C: visit 1, 4 and 7. |
![]()
Figure/Graphic 1: Moxonidine - Clinical evaluation
Study flow chart. Clinical evaluation: all visits; ambulatory blood pressure: visit 1 and 7; venous and arterial blood sample for assessment of catecholamines, insulin, glucose, leptin, plasma renin activity, plama aldosterone, total cholesterol, triglycerides, HDL-C and LDL-C: visit 1, 4 and 7. |